Scilex Holding Company (SCLX)
NASDAQ: SCLX · Real-Time Price · USD
0.965
-0.007 (-0.68%)
At close: Nov 4, 2024, 4:00 PM
0.962
-0.003 (-0.29%)
After-hours: Nov 4, 2024, 7:21 PM EST
Scilex Holding Company Employees
Scilex Holding Company had 105 employees as of December 31, 2023. The number of employees increased by 15 or 16.67% compared to the previous year.
Employees
105
Change (1Y)
15
Growth (1Y)
16.67%
Revenue / Employee
$484,124
Profits / Employee
-$1,633,648
Market Cap
127.09M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 105 | 15 | 16.67% |
| Dec 31, 2022 | 90 | 14 | 18.42% |
| Dec 31, 2021 | 76 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| American Well | 1,104 |
| Akoya Biosciences | 330 |
| Adagene | 174 |
| Pro-Dex | 148 |
| Fractyl Health | 102 |
| KORU Medical Systems | 82 |
| Journey Medical | 41 |
| Avalo Therapeutics | 19 |
SCLX News
- 5 days ago - Scilex Pharmaceuticals Inc, a Wholly Owned Subsidiary of Scilex Holding Company, Announces Successful End of Phase II Meeting with FDA Leading to an Agreed Path Forward to NDA Upon Completion of Phase III Trials for Blockbuster Product Candidate, SP-103 (Lidocaine Topical System) 5.4%, a Next-Generation, Triple-Strength Formulation of ZTlido, for the Treatment of Chronic Neck Pain Associated with Muscle Spasms - GlobeNewsWire
- 6 days ago - Scilex Holding Company, Following its Prior Announcement of the Record Date for a Dividend of Preferred Stock, Reiterates Information Previously Provided to Scilex Stockholders Regarding Manipulative and Naked Short Selling of Scilex Common Stock - GlobeNewsWire
- 7 days ago - Scilex Holding Company sets November 7, 2024 as the Record Date for a Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary - GlobeNewsWire
- 20 days ago - Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, Provides Timing to File in October 2024 a Registration Statement on Form S-4 with the SEC relating to the Previously Announced Proposed Business Combination Between Semnur and Denali with a Pre-Transaction Equity Value of $2.5 Billion - GlobeNewsWire
- 27 days ago - Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Quarter Ended September 30, 2024 - GlobeNewsWire
- 27 days ago - Scilex Holding Company Announces Closing of a $50 Million Registered Convertible Financing - GlobeNewsWire
- 4 weeks ago - Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt - PRNewsWire
- 4 weeks ago - Scilex Holding Company Announces Signing of a $50 Million Registered Convertible Financing to Refinance and Restructure Existing Debt & Further Strengthens Financial Profile - GlobeNewsWire